One week to Dr. Gobburu's webinar

The “Learn & Apply” Paradigm in Drug Development: How Disease-Drug-Trial Models Can Aid Decisions by Joga Gobburu, PhD Division of Pharmacometrics US Food & Drug Administration April 18, 2011 1:00 - 2:00 pm EDT You are invited to attend Dr. Gobburu’s webinar The “Learn & Apply” Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00). This talk will summarize the state of the art in applying drug-disease-trial modeling to decision-making processes in drug development. This is the first of the monthly world-wide webinar series “Impact of Modeling & Simulation in Drug Development” hosted by Rosa & Co. LLC. The purpose of the “Impact” series is to foster the use of M&S activities in all phases of drug development by illustrating the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. The series is intended for drug development project team members from discovery to phase 4 clinical trials. This includes pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, and other interested professionals. Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar. Please allow 5-10 minutes for a Java applet to be installed on your computer prior to joining our webinars for the first time. Toufigh Gordi, PhD Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Rosa & Co. LLC: www.rosaandco.com E-mail: [email protected] Tel.: 408-480-7314 Fax: 408-370-9810 The information contained in this e-mail message, e-mail message sequence, and/or any enclosures is confidential, and it may be privileged and protected from unauthorized use and/or disclosure. If you are not the intended recipient, any use, dissemination, distribution, or copying is strictly prohibited. If you received this e-mail in error, PLEASE NOTIFY THE SENDER immediately and destroy this message, any enclosures, and any copies of the message and/or the enclosures. Thank you.